BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 356963)

  • 1. Covalent intercalative binding to DNA in relation to the mutagenicity of hydrocarbon epoxides and N-acetoxy-2-acetylaminofluorene.
    Drinkwater NR; Miller JA; Miller EC; Yang NC
    Cancer Res; 1978 Oct; 38(10):3247-55. PubMed ID: 356963
    [No Abstract]   [Full Text] [Related]  

  • 2. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 3. Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA?
    Geacintov NE
    Carcinogenesis; 1986 May; 7(5):759-66. PubMed ID: 3698204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
    Malaveille C; Hautefeuille A; Perin-Roussel O; Saguem S; Croisy-Delcey M; Zajdela F; Bartsch H
    Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis.
    Sims P; Grover PL
    Adv Cancer Res; 1974; 20():165-274. PubMed ID: 4617500
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenic effects of styrene and styrene oxide.
    Busk L
    Mutat Res; 1979 Jul; 67(3):291-8. PubMed ID: 384233
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of ultimate mutagenic species by diverse enzymes.
    Oesch F; Doehmer J; Friedberg T; Glatt H; Oesch-Bartlomowicz B; Platt KL; Steinberg P; Utesch D; Thomas H
    Prog Clin Biol Res; 1990; 340B():49-65. PubMed ID: 2168050
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts.
    Day BW; Naylor S; Gan LS; Sahali Y; Nguyen TT; Skipper PL; Wishnok JS; Tannenbaum SR
    Cancer Res; 1990 Aug; 50(15):4611-8. PubMed ID: 2369737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of methylvinyl ketone in Salmonella typhimurium TA100--indication for epoxidation as an activation mechanism.
    Neudecker T; Eder E; Deininger C; Hoffman C; Henschler D
    Mutat Res; 1989 Oct; 227(2):131-4. PubMed ID: 2677713
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
    Glatt H; Oesch F
    Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; PiƩe A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutagenicity of the metabolites of the epoxide-diol pathway of safrole and its analogs. Study on Salmonella typhimurium].
    Dorange JL; Delaforge M; Janiaud P; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(5):1041-8. PubMed ID: 146546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supercoiled DNA.
    Bauer WR; Crick FH; White JH
    Sci Am; 1980 Jul; 243(1):100-13. PubMed ID: 6256851
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and mutagenicity of styrene and styrene oxide.
    Vainio H; Norppa H; Belvedere G
    Prog Clin Biol Res; 1984; 141():215-25. PubMed ID: 6718374
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
    Rosin MP; Stich HF
    Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of aliphatic epoxides.
    Wade DR; Airy SC; Sinsheimer JE
    Mutat Res; 1978 Nov; 58(2-3):217-23. PubMed ID: 370573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicities of styrene oxide derivatives on Salmonella typhimurium (TA 100): relationship between mutagenic potencies and chemical reactivity.
    Sugiura K; Kimura T; Goto M
    Mutat Res; 1978 Nov; 58(2-3):159-65. PubMed ID: 370568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Differential mutagenicity of epoxides.
    Glatt HR; Oesch R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R75. PubMed ID: 1143492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.